Research Article

Quality of life of diabetic foot patients and affecting factors

Volume: 59 Number: 4 December 30, 2020
EN TR

Quality of life of diabetic foot patients and affecting factors

Abstract

Aim: To evaluate the quality of life of diabetic foot patients and affecting factors. Materials and Methods: The data of the study were collected from 171 patients who applied to the diabetic foot council of a university hospital between January - March 2020. For the collection of the data, the individual identification form, and the Diabetic Foot Scale - Short Form were used. In this scale, the sub-dimensions’ and scale total scores are range from 0 to 100, and the high mean score indicates a high quality of life, the low mean of score indicates a low quality of life. Research data were analyzed with IBM SPSS 25.0 software package. Results: Of the patients, 67.3% were male, 84.8% were married, and the mean age was 61.57 ± 10.03 years. The quality of life scores of women (p = 0.009), those receiving insulin therapy (p = 0.004), non-smokers (p = 0.027), those who do not consume alcohol (p = 0.030), and individuals who do not have any concomitant chronic disease (p = 0.003) was found to be at a high level. In regression estimation, it was found that receiving insulin therapy (β = -0.23, p = 0.024) and not having any concomitant chronic disease (β = -0.17, p = 0.037) positively affected the quality of life. Conclusion: As a result, it was observed that the quality of life of diabetic foot patients was at a moderate level, and there was a difference between the groups in terms of gender, type of treatment, smoking, alcohol consumption and accompanying chronic disease. It was determined that the type of treatment and accompanying chronic disease have a significant effect on the quality of life in diabetic foot patients.

Keywords

Supporting Institution

Çalışma herhangi bir kurum/kuruluş tarafından desteklenmemiştir.

References

  1. Saeedi P, Petersohn I, Salpea, P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract 2019; 157: 107843.
  2. Satman İ, Grubu TIÇ. TURDEP-II Sonuçları. Türk Endokronoloji ve Metabolizma Derneği [Updated: 2011 Cited: 23.03.2020]. Avaible from: http://www.turkendokrin.org/files/file/TURDEP_ II_2011.pdf Son Erişim Tarihi: 23.03.2020.
  3. Al-Rubeaan K, Al Derwish M, Ouizi S, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One 2015; 10 (5): e0124446.
  4. Nather A, Bee CS, Huak CY, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications 2008; 22 (2): 77-82.
  5. Bann CM, Fehnel SE, Gagnon DD. Development and validation of the Diabetic Foot Ulcer Scale-short form (DFS-SF). Pharmacoeconomics 2013; 21 (17): 1277-90.
  6. Toygar İ, Hançerlioğlu S, Gül S, Utku T, Yıldırım Şimşir I, Çetinkalp Ş. Turkish Adaptation of Diabetic Foot Ulcer Scale – Short Form. International Journal of Lower Extremity Wounds The International Journal of Lower Extremity Wounds. 2020; 19 (3): 269-274.
  7. PrasannaKumar HR, Mahesh MG, Menon VB, Srinath KM, Shashidhara KC, Ashok P. Patient Self-reported quality of life assessment in Type 2 diabetes mellitus: A pilot study. Niger J Clin Pract 2018; 21: 343-9.
  8. Levterova B, Levterov G, Dragova E. Quality of life in patients with type 2 diabetes mellitus in Bulgaria: a cross-sectional study. European Journal of Preventive Medicine 2016; 4 (1): 7-12.

Details

Primary Language

Turkish

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

December 30, 2020

Submission Date

April 21, 2020

Acceptance Date

June 6, 2020

Published in Issue

Year 1970 Volume: 59 Number: 4

Vancouver
1.İsmail Toygar, Sadik Hançerlioğlu, Ilgın Yıldırım Şimşir, Şevki Çetinkalp. Diyabetik ayak hastalarının yaşam kalitesi ve etkileyen faktörler. EJM. 2020 Dec. 1;59(4):272-9. doi:10.19161/etd.834143

Cited By

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.